中国卫生质量管理2024,Vol.31Issue(2) :76-79.DOI:10.13912/j.cnki.chqm.2024.31.2.18

医疗器械临床试验立项审查环节质量分析及防范策略

Quality Analysis and Preventive Measures in the Project Approval Review Link of Medical Device Clinical Trials

赵同香 马丽萍 庞华 蒋向明
中国卫生质量管理2024,Vol.31Issue(2) :76-79.DOI:10.13912/j.cnki.chqm.2024.31.2.18

医疗器械临床试验立项审查环节质量分析及防范策略

Quality Analysis and Preventive Measures in the Project Approval Review Link of Medical Device Clinical Trials

赵同香 1马丽萍 1庞华 2蒋向明1
扫码查看

作者信息

  • 1. 北京大学首钢医院 北京 100144
  • 2. 北京核工业医院 北京 100840
  • 折叠

摘要

立项审查是提高医疗器械临床试验质量的关键环节.通过对立项阶段发现的典型问题以案例的形式进行综合分析.提出,国家药监部门需进一步完善规章制度,申办者应承担临床试验质量管理责任,临床试验机构应建立完善的立项审查机制,研究者应提高规范意识,以保证试验质量和受试者权益.

Abstract

Project approval review is the key link to improve the quality of medical device clinical trials.Through a comprehensive analysis of typical problems found in the project initialization stage in the form of cases,it is suggested that the state drug regulatory authorities should further improve the regulations,that the applicants should assume the responsibility of clinical trial quality management,that the clinical trial institutions should establish a sound mechanism for project approval review,and that the researchers should enhance their normative awareness,so as to ensure the qual-ity of the trial and the interests of the subjects.

关键词

医疗器械/临床试验/立项审查/环节质量

Key words

Medical Devices/Clinical Trials/Project Approval Review/Link Quality

引用本文复制引用

出版年

2024
中国卫生质量管理
中国医院协会,陕西省人民医院

中国卫生质量管理

CSTPCD
影响因子:1.091
ISSN:1006-7515
参考文献量13
段落导航相关论文